<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37651035</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Post-recovery impact of the second and third SARS-CoV-2 infection waves on healthcare resource utilization in Lombardy, Italy.</ArticleTitle><Pagination><StartPage>2011</StartPage><EndPage>2018</EndPage><MedlinePgn>2011-2018</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-023-03396-4</ELocationID><Abstract><AbstractText>The administrative claims database of the Italian region Lombardy, the first in Europe to be hit by the SARS-CoV-2 pandemic, was employed to evaluate the impact on healthcare resource utilization following recovery from the second (mainly alpha-related variant) and third (delta-related) infection waves. 317,164 individuals recovered from the infection and became negative after the second wave, 271,180 after the third. Of them, 1571 (0.5%) and 1575 (0.6%) died in the first 6 post-negativization months. In the remaining cases (315,593 after the second wave and 269,605 after the third), hospitalizations, attendances to emergency rooms and outpatient visits were compared with those recorded in the same pre-pandemic time periods in 2019. Dispensation of drugs as well as of imaging, and functional and biochemical diagnostic tests were also compared as additional proxies of the healthcare impact of the SARS-CoV-2 infection waves. Following both waves, hospitalizations, attendances at emergency rooms, and outpatient visits were similar in number and rates to the pre-pandemic periods. However, there was an increased dispensation a number of drugs and diagnostic tests, particularly those addressing the cardiorespiratory and blood systems. In a large region such as Lombardy taken as a relevant model because early and severely hit by the SARS-CoV-2 pandemic, the post-COVID burden on healthcare facilities was mildly relevant in cases who recovered from the second and third infection waves regarding such pivotal events as deaths, hospitalizations, and need for emergency room and outpatient visits, but was high regarding the dispensation of some drug classes and types of diagnostic tests.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Societ&#xe0; Italiana di Medicina Interna (SIMI).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harari</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine, Multimedica IRCSS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mannucci</LastName><ForeName>Pier Mannuccio</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-1915-3897</Identifier><AffiliationInfo><Affiliation>Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Pace 9, 20122, Milan, Italy. piermannuccio.mannucci@policlinico.mi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nobili</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galbussera</LastName><ForeName>Alessia Antonella</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortino</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Welfare Directorate, Regione Lombardia, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leoni</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>General Welfare Directorate, Regione Lombardia, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remuzzi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Avanzo</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tettamanti</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Administrative database</Keyword><Keyword MajorTopicYN="N">Diagnostic tests</Keyword><Keyword MajorTopicYN="N">Drugs</Keyword><Keyword MajorTopicYN="N">Lombardy region</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Polypharmacy</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37651035</ArticleId><ArticleId IdType="doi">10.1007/s11739-023-03396-4</ArticleId><ArticleId IdType="pii">10.1007/s11739-023-03396-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Consolandi E (2021) Chapter 1.3&#x2014;Evolution and intensity of infection in Lombardy. In: Casti E, Adobati F, Negri I (eds) Mapping the epidemic: a systemic geography of COVID-19 in Italy, volume 9. https://www.sciencedirect.com/science/article/abs/pii/B9780323910613000089 . Accessed Mar 2023</Citation></Reference><Reference><Citation>https://www.regione.lombardia.it/wps/portal/istituzionale/HP/vaccinazionicovid . Accessed Mar 2023</Citation></Reference><Reference><Citation>https://opendatamds.maps.arcgis.com/apps/dashboards/0f1c9a02467b45a7b4ca12d8ba296596 . Accessed Mar 2023</Citation></Reference><Reference><Citation>Caramello V, Catalano A, Macciotta A, Dansero L, Sacerdote C, Costa G et al (2022) Improvements throughout the three waves of COVID-19 pandemic: results from 4 million inhabitants of North-West Italy. J Clin Med 11(15):4304</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154304</ArticleId><ArticleId IdType="pubmed">35893395</ArticleId><ArticleId IdType="pmc">9332615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci PM, Galbussera AA, D&#x2019;Avanzo B, Tettamanti M, Remuzzi G, Fortino I, Leoni O, Harari S, Nobili A (2023) Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy. Intern Emerg Med. https://doi.org/10.1007/s11739-023-03315-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-023-03315-7</ArticleId><ArticleId IdType="pubmed">37656408</ArticleId><ArticleId IdType="pmc">10030070</ArticleId></ArticleIdList></Reference><Reference><Citation>Havers FP, Pham H, Taylor CA, Whitaker M, Patel K, Anglin O et al (2022) COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US States, January 2021 to April 2022. JAMA Intern Med 182(10):1071&#x2013;1081</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.4299</ArticleId><ArticleId IdType="pubmed">36074486</ArticleId><ArticleId IdType="pmc">9459904</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor CA, Whitaker M, Anglin O, Milucky J, Patel K, Pham H et al (2022) COVID-19-associated hospitalizations among adults during SARS-CoV-2 delta and omicron variant predominance, by race/ethnicity and vaccination status&#x2014;COVID-NET, 14 states, July 2021&#x2013;January 2022. MMWR Morb Mortal Wkly Rep 71(12):466&#x2013;473</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7112e2</ArticleId><ArticleId IdType="pubmed">35324880</ArticleId><ArticleId IdType="pmc">8956338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C et al (2023) Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(22)00801-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00801-5</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId><ArticleId IdType="pmc">10014083</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums DV (2021) Editorial: long-COVID, or post-COVID syndrome, and the global impact on health care. Med Sci Monit 27:e933446</Citation><ArticleIdList><ArticleId IdType="pubmed">34092779</ArticleId><ArticleId IdType="pmc">8194290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Normand K, Zhaoyun Y, Torres-Castro R (2021) Long-term impact of COVID-19: a systematic review of the literature and meta-analysis. Biomedicines. 9(8):900</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId><ArticleId IdType="pmc">8389585</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M et al (2022) Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 28(5):657&#x2013;666</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId><ArticleId IdType="pmc">8812092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R, Zentilin L, Correa R, Colliva A, Silvestri F, Zacchigna S et al (2023) Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J Pathol 259(3):254&#x2013;263</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId><ArticleId IdType="pmc">10107739</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci PM, Nobili A, Tettamanti M, D&#x2019;Avanzo B, Galbussera AA, Remuzzi G et al (2022) Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy. J Intern Med 292(3):450&#x2013;462</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13493</ArticleId><ArticleId IdType="pubmed">35373863</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci PM, Nobili A, Tettamanti M, D&#x2019;Avanzo B, Galbussera AA, Remuzzi G et al (2022) Progressive decrease of the healthcare impact of the post-COVID condition after the first disease wave in Lombardy, Italy. J Intern Med 292(6):961&#x2013;964</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13554</ArticleId><ArticleId IdType="pubmed">35968565</ArticleId></ArticleIdList></Reference><Reference><Citation>ATC/DDD Index 2021. https://www.whocc.no/atc_ddd_index/ . Accessed Mar 2023</Citation></Reference><Reference><Citation>McNaughton CD, Austin PC, Sivaswamy A, Fang J, Abdel-Qadir H, Daneman N et al (2022) Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study. CMAJ 194(40):E1368&#x2013;E1376</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.220728</ArticleId><ArticleId IdType="pubmed">36252983</ArticleId><ArticleId IdType="pmc">9616149</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich HG, Brockmann SO, G&#xf6;pel S, Kindle G et al (2022) Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ 379:e071050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsioutis C, Tofarides A, Spernovasilis N (2022) Transition beyond the acute phase of the COVID-19 pandemic: need to address the long-term health impacts of COVID-19. World J Clin Cases 10(27):9967&#x2013;9969</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i27.9967</ArticleId><ArticleId IdType="pubmed">36186173</ArticleId><ArticleId IdType="pmc">9516898</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson C, Davis D, Roche M, Bissett B, Roberts C, Turner M et al (2022) What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic review. J Med Virol 94(12):5653&#x2013;5668</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28086</ArticleId><ArticleId IdType="pubmed">36002399</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators (2022) Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328(16):1604&#x2013;1605</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">9552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapin A, Boyer FC, Mourvillier B, Giordano Orsini G, Launois C et al (2022) Post-intensive care syndrome prevalence six months after critical COVID-19: comparison between first and second waves. J Rehabil Med 54:jrm00339. https://doi.org/10.2340/jrm.v54.4363</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/jrm.v54.4363</ArticleId><ArticleId IdType="pubmed">36193697</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.istat.it/it/files/2020/03/tabella-regionale-decessi-totali-14022023-1.xlsx . Accessed Mar 2023</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ . Accessed Mar 2023</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Italy. https://covid19.who.int/region/euro/country/it . Accessed Mar 2023</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>